ConductScience.org, home

Paper33280239

Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.

Li L and 9 others. J Cell Mol Med, 2021. Cited by 58 papers, by iCite.

Cite this record

ConductScience Library. Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis. Papers, record 33280239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33280239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.
PubMed
Journal
J Cell Mol Med
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
3.93
iCite
Revised in PubMed
2022-10-05
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li LLing
2Wei TTiantian
3Liu SShuyun
4Wang CChengshihttps://orcid.org/0000-0002-0650-4109
5Zhao MMeng
6Feng YYanhuan
7Ma LLianghttps://orcid.org/0000-0001-8327-7969
8Lu YYanronghttps://orcid.org/0000-0002-3728-222X
9Fu PPing
10Liu JJingpinghttps://orcid.org/0000-0001-8364-639X

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement ActivationMajor topic
Complement C5Major topic
Diabetic NephropathiesMajor topic
Gastrointestinal TractMajor topic
KidneyMajor topic
STAT3 Transcription FactorMajor topic
Signal TransductionMajor topic
Animals
Diabetes Mellitus, Experimental
Endothelial Cells
Fatty Acids
Gastrointestinal Microbiome
Homeostasis
Humans
Inflammation
Mice
Models, Biological
Oxidative Stress
Receptor, Anaphylatoxin C5a
Transcriptome

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
81700634National Natural Science Foundation of ChinaPubMed
82070711National Natural Science Foundation of ChinaPubMed
Z20192002National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University.PubMed
2019YFS0279Key Research and Development (R&D) Project funded by Science and Technology Department of Sichuan ProvincePubMed

Source PubMed

Download CSV of grants

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121752957Transcriptome analysis of human diabetic kidney disease.Diabetes2011https://conductscience.org/library/papers/21752957PubMed
231510052High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells.Int J Mol Sci2019https://conductscience.org/library/papers/31510052PubMed
325589612Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion.J Am Soc Nephrol2015https://conductscience.org/library/papers/25589612PubMed
431925859Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease.Cell Prolif2020https://conductscience.org/library/papers/31925859PubMed
524833634Microbiota and diabetes: an evolving relationship.Gut2014https://conductscience.org/library/papers/24833634PubMed
622674334Interactions between the microbiota and the immune system.Science2012https://conductscience.org/library/papers/22674334PubMed
725003516Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance.Gut Microbes2014https://conductscience.org/library/papers/25003516PubMed
820664075Gut microbiota in health and disease.Physiol Rev2010https://conductscience.org/library/papers/20664075PubMed
924375052The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?Nat Rev Nephrol2014https://conductscience.org/library/papers/24375052PubMed
1021808634Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.Front Microbiol2011https://conductscience.org/library/papers/21808634PubMed
1112472776A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats.Kidney Int2003https://conductscience.org/library/papers/12472776PubMed
1216384831Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats.Nephrol Dial Transplant2006https://conductscience.org/library/papers/16384831PubMed
1318043660Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.ISME J2007https://conductscience.org/library/papers/18043660PubMed
1431851794Glomerular podocytes in diabetic renal disease.Adv Clin Exp Med2019https://conductscience.org/library/papers/31851794PubMed
1524143873Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: a meta-analysis of 39 studies involving more than 20,000 participants.Scand J Infect Dis2013https://conductscience.org/library/papers/24143873PubMed
1633280239Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.J Cell Mol Med2021https://conductscience.org/library/papers/33280239PubMed
1724080802The role of the glomerular endothelium in albumin handling.Nat Rev Nephrol2013https://conductscience.org/library/papers/24080802PubMed
1821693741Temporal trends in the prevalence of diabetic kidney disease in the United States.JAMA2011https://conductscience.org/library/papers/21693741PubMed
1922554833VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment?Metabolism2012https://conductscience.org/library/papers/22554833PubMed
2032576600Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin.J Am Soc Nephrol2020https://conductscience.org/library/papers/32576600PubMed

See all 57 referencesDownload CSV of references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42939591Complement-Metabolic Inflammation Crosstalk: Molecular Mechanisms and Therapeutic Targets in Type 2 Diabetes and Its Complications.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939591PubMed
42076830Qiling Hushen Formula Ameliorates Type 2 Diabetic Kidney Disease via Gut-Kidney Axis Restoration and TLR4/NF-κB/NLRP3 Suppression.J Diabetes Res2026https://conductscience.org/library/papers/42076830PubMed
41916963Complement 5a receptor 2 attenuates diabetic kidney disease by promoting mitochondria-associated endoplasmic reticulum membrane formation mediated by PSS-MFN2 interaction.Cell Discov2026https://conductscience.org/library/papers/41916963PubMed
41835120Gut Microbiota Dysbiosis and Metabolite Imbalance Mediate Diabetic Kidney Disease Inflammation: Mechanisms and Intervention Strategies Targeting Gut-Kidney Axis and NF-κB/NLRP3 Pathways.J Inflamm Res2026https://conductscience.org/library/papers/41835120PubMed
41657872The Role of Complement Component C5a in the Pathogenesis of Diabetic Kidney Disease: A New Kid on the Block?Cureus2026https://conductscience.org/library/papers/41657872PubMed
41440851SGLT2 Inhibitors Confer Cardiovascular Protection via the Gut-Kidney-Heart Axis: Mechanisms and Translational Perspectives.J Cardiovasc Dev Dis2025https://conductscience.org/library/papers/41440851PubMed
41189475Post-ischemia and reperfusion kidney injury is mitigated in a novel complement 5 knockout rat.Physiol Rep2025https://conductscience.org/library/papers/41189475PubMed
41096893A Targeted Blockade of Terminal C5a Is Critical to Management of Sepsis and Acute Respiratory Distress Syndrome: The Mechanism of Action of Vilobelimab.Int J Mol Sci2025https://conductscience.org/library/papers/41096893PubMed
40970493Progress in the study of the role of C5a-induced tubular cell senescence in the progression of diabetic kidney disease.Ann Med2025https://conductscience.org/library/papers/40970493PubMed
40944292Gut Microbiome-Derived Short-Chain Fatty Acids in Glomerular Protection and Modulation of Chronic Kidney Disease Progression.Nutrients2025https://conductscience.org/library/papers/40944292PubMed
40840920Mechanism of Rhizoma Chuanxiong for the treatment of diabetic kidney disease based on network pharmacology.Ren Fail2025https://conductscience.org/library/papers/40840920PubMed
40830297Causal Relationship Between Serum Zinc Levels and Diabetic Kidney Disease (DKD): A Plasma Proteomics Mediation Study.Biol Trace Elem Res2026https://conductscience.org/library/papers/40830297PubMed
40775226Urinary Complement proteome strongly linked to diabetic kidney disease progression.Nat Commun2025https://conductscience.org/library/papers/40775226PubMed
40657042Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney Disease.Drug Des Devel Ther2025https://conductscience.org/library/papers/40657042PubMed
40638782The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO study.Am J Health Syst Pharm2026https://conductscience.org/library/papers/40638782PubMed
40352935Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies.Front Immunol2025https://conductscience.org/library/papers/40352935PubMed
40072066Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy.Cells2025https://conductscience.org/library/papers/40072066PubMed
39753879Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies.Sci Rep2025https://conductscience.org/library/papers/39753879PubMed
39636415Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis.Cell Mol Life Sci2024https://conductscience.org/library/papers/39636415PubMed
39549180Discussion on the treatment of diabetic kidney disease based on the "gut-fat-kidney" axis.Int Urol Nephrol2025https://conductscience.org/library/papers/39549180PubMed

See all 44 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C5727PubTator's text mininghttps://conductscience.org/library/genes/727NCBI Gene
C5AR1728PubTator's text mininghttps://conductscience.org/library/genes/728NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33280239

GET https://conductscience.org/api/papers/v1/33280239/references?page=2